1. U. S. Cancer Statistics Working Group. United States Cancer Statistics:1999–2007 Incidence and Mortality Web-based Report. In. Atlanta: US: Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute. 2010.
2. Surveillance Epidemiology and End Results. SEER Stats Fact Sheet: Prostate. 2013.
http://www.seer.cancer.gov/statfacts/html/prost.html
3. Schymura MJ, Kahn AR, German RR, Hsieh MC, Cress RD, Finch JL, Fulton JP, Shen T, Stuckart E. Factors associated with initial treatment and survival for clinically localized prostate cancer: results from the CDC-NPCR Patterns of Care Study (PoC1). BMC Cancer. 2010;10(152):152.
4. Wilt TJ, MacDonald R, Rutks I, Shamliyan TA, Taylor BC, Kane RL. Systematic review: comparative effectiveness and harms of treatments for clinically localized prostate cancer. Ann Intern Med. 2008;148(6):435–48.
5. Sun F, Oyesanmi O, Fontanarosa J, Reston J, Guzzo T, Schoelles K. Therapies for Clinically Localized Prostate Cancer: Update of a 2008 Systematic Review. Comparative Effectiveness Review No. 146. (Prepared by the ECRI Institute–Penn Medicine Evidence-based Practice Center under Contract No. 290-2007-10063.) AHRQ Publication No. 15-EHC004-EF.. In: Comparative Effectiveness Review. Rockville, MD: Agency for Healthcare Research and Quality; 2014.